Saturday, February 21, 2026
18.4 C
Bengaluru

Doctor Rx

[wpfilebase tag=file id=49 tpl=download-button /]

Inside this Issue

1. New Era in Pharma Growth by Cambridge Consultants

Innovation and technology are key to growth of pharma companies in emerging markets according to a workshop conducted by Cambridge Consultants in Mumbai.

2. India Makes it Big at Cannes Lions Health 2015 – MedicinMan Report

Indian agencies picked up 10 shortlists in the healthcare category with Ogilvy & Mather, Mumbai and Medulla Communications winning a Silver Lion and a Bronze Lion respectively.

3. Leading with Conviction by Sunil Bajaj

In order to lead with conviction, leaders must make the effort to develop themselves and others.

4. Pharma Sales Management and the New Front-line Manager by Anup Soans

How a new Front-line Manager can make the transition from being a great performer to getting great performance from others.

5. Do We Need Front-line Managers? by K. Hariram

A hard look at the impact of frontline managers on pharma top-lines and bottom-lines.

6. Winning the Casino Royale of Multi-Channel Marketing by Phanish Chandra

How the changing habits of India’s net-savvy and mobile friendly population is impacting pharma’s marketing strategies – and how to set yourself up to win.

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img